Business Description
JFL Life Sciences Ltd
ISIN : INE0LA901015
Total Employee Number:
39Compare
Compare
Traded in other countries / regions
JFLLIFE.India IPO Date
2022-09-08Description
JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Equity-to-Asset | 0.55 | |||||
Debt-to-Equity | 0.27 | |||||
Debt-to-EBITDA | 1.3 | |||||
Interest Coverage | 7.26 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.74 | |||||
Beneish M-Score | -2.3 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 34.7 | |||||
3-Year EBITDA Growth Rate | 9.3 | |||||
3-Year EPS without NRI Growth Rate | 14 | |||||
3-Year Book Growth Rate | 51.8 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 70.93 | |||||
9-Day RSI | 69.86 | |||||
14-Day RSI | 66.2 | |||||
3-1 Month Momentum % | 7.03 | |||||
6-1 Month Momentum % | -12.48 | |||||
12-1 Month Momentum % | -35.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.88 | |||||
Quick Ratio | 1.15 | |||||
Days Inventory | 107.86 | |||||
Days Sales Outstanding | 135.23 | |||||
Days Payable | 83.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Payout Ratio | 0.07 | |||||
Shareholder Yield % | -13.37 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 19.42 | |||||
Operating Margin % | 8.78 | |||||
Net Margin % | 5.07 | |||||
EBITDA Margin % | 9.9 | |||||
FCF Margin % | -4.79 | |||||
OCF Margin % | -4.3 | |||||
ROE % | 11.09 | |||||
ROA % | 6.47 | |||||
ROIC % | 10.39 | |||||
3-Year ROIIC % | 6.33 | |||||
ROC (Joel Greenblatt) % | 15.61 | |||||
ROCE % | 18.67 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 8.81 | |||||
PE Ratio without NRI | 8.81 | |||||
PEG Ratio | 0.27 | |||||
PS Ratio | 0.45 | |||||
PB Ratio | 0.93 | |||||
Price-to-Tangible-Book | 0.93 | |||||
EV-to-EBIT | 6.62 | |||||
EV-to-EBITDA | 5.81 | |||||
EV-to-Revenue | 0.58 | |||||
EV-to-FCF | -12.02 | |||||
Price-to-GF-Value | 0.3 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.35 | |||||
Price-to-Graham-Number | 0.6 | |||||
| Price-to-Net-Current-Asset-Value | 1.36 | |||||
Earnings Yield (Greenblatt) % | 15.11 | |||||
FCF Yield % | -10.72 | |||||
Forward Rate of Return (Yacktman) % | 11.61 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
JFL Life Sciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 820.423 | ||
| EPS (TTM) (₹) | 1.203 | ||
| Beta | 0.87 | ||
| 3-Year Sharpe Ratio | -0.02 | ||
| 3-Year Sortino Ratio | -0.03 | ||
| Volatility % | 33.16 | ||
| 14-Day RSI | 66.2 | ||
| 14-Day ATR (₹) | 0.321234 | ||
| 20-Day SMA (₹) | 9.6025 | ||
| 12-1 Month Momentum % | -35.18 | ||
| 52-Week Range (₹) | 8.55 - 15.272727 | ||
| Shares Outstanding (Mil) | 34.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
JFL Life Sciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
JFL Life Sciences Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| 3:1 Stock Split | 2024-09-24 | 21.22 (-3.19%) | ||
| INR 0.079545 Cash Dividend | 2024-09-13 | 21.05 (+0.00%) |
Show
Entries
JFL Life Sciences Ltd Frequently Asked Questions
What is JFL Life Sciences Ltd(NSE:JFLLIFE)'s stock price today?
The current price of NSE:JFLLIFE is ₹10.60. The 52 week high of NSE:JFLLIFE is ₹15.27 and 52 week low is ₹8.55.
When is next earnings date of JFL Life Sciences Ltd(NSE:JFLLIFE)?
The next earnings date of JFL Life Sciences Ltd(NSE:JFLLIFE) is .
Does JFL Life Sciences Ltd(NSE:JFLLIFE) pay dividends? If so, how much?
JFL Life Sciences Ltd(NSE:JFLLIFE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on JFL Life Sciences Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers